• Issues related to the opioid epidemic and their attendant health consequences, including substance use disorder, overdose, infectious disease and neonatal abstinence syndrome.
• Viral hepatitis and HIV/AIDS prevention and treatment

Duration: October 10, 2011 to June 30, 2015

General Issues: Alcohol & Drug Abuse, Health Issues, Budget/Appropriations, Civil Rights/Civil Liberties, Law Enforcement/Crime/Criminal Justice, Medical/Disease Research/Clinical Labs, Pharmacy, Foreign Relations

Spending: about $274,500 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2011: U.S. Senate, House of Representatives, Substance Abuse & Mental Health Services Administration (SAMHSA), Office of Natl Drug Control Policy (NDCP), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS)